本页面由Tiger Trade Technology Pte. Ltd.提供服务

天演药业

2.98
+0.310011.61%
盘后2.980.00000.00%19:34 EST
成交量:15.34万
成交额:44.14万
市值:1.40亿
市盈率:-4.64
高:3.04
开:2.62
低:2.61
收:2.67
52周最高:3.19
52周最低:1.30
股本:4,713.13万
流通股本:1,273.25万
量比:1.22
换手率:1.20%
股息:- -
股息率:- -
每股收益(TTM):-0.6428
每股收益(LYR):-0.7423
净资产收益率:-63.26%
总资产收益率:-24.89%
市净率:3.70
市盈率(LYR):-4.01

数据加载中...

2025/05/28

SEC问询函

Form CORRESP - Correspondence
2025/05/23

SEC问询函

Form CORRESP - Correspondence
2025/03/24

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/11/07

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/03/29

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/03/01

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/19

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/07/10

SEC问询函

Form CORRESP - Correspondence
2023/06/16

SEC问询函

Form CORRESP - Correspondence
2023/04/28

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/17

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/02/06

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/05/24

SEC问询函

CORRESP [Cover] - Correspondence
2022/05/13

SEC问询函

CORRESP [Cover] - Correspondence
2022/04/29

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/04/26

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/11

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/26

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/26

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals